BG Medicine shares have declined approximately 25 percent year-to-date. The company in their recent earnings release stated that they expect to launch the CardioSCORE test in Europe sometime in the first half of 2013.
Going forward ... (see research report)
Copyright ® 2016. The Bedford Report. All Rights Reserved.